Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-01-24 @ 7:03 PM
Study NCT ID:
NCT05385705
Status:
TERMINATED
Last Update Posted:
2025-09-22
First Post:
2022-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020
Sponsor:
Vall d'Hebron Institute of Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VHIO20002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None